NiXEN has co-invested in HT Médica alongside Fremman to support the company's growth in the Spanish diagnostic imaging market.
Information on the Target
HT Médica is one of the leading operators of radiology and diagnostic imaging services in Spain. The company operates 20 diagnostic imaging centers and 2 laboratories strategically located across Andalusia, Castile-La Mancha, Asturias, and Madrid.
HT Médica offers a diverse portfolio of services, including MRI, CT scans, ultrasound, X-rays, and laboratory services. The company has built a strong reputation in the market, evidenced by its extensive experience and leadership in clinical settings.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Spain
The healthcare sector in Spain, particularly the diagnostic imaging market, has shown significant growth due to advancements in technology and the incr
Similar Deals
Management Team of Ortopedia Sumisan, S.L. → Ortopedia Sumisan, S.L.
2025
Ortopedia Sumisan, S.L. → Ortopedia Sumisan, S.L.
2025
NiXEN → Palex
2024
Miura Partners → HTBA
2024
Abac Capital and Pronokal's management team → Pronokal
2023
NiXEN
invested in
HT Médica
in 2024
in a Management Buyout / Buy-In (MBO) deal